Labcorp Holdings Inc's Corporate Customers have recorded an advance in their cost of revenue by 8.59 % in the 1 quarter 2026 year on year, sequentially costs of revenue were trimmed by -6.12 %. During the corresponding time, Labcorp Holdings Inc recorded a revenue increase by 5.75 % year on year, sequentially revenue grew by 0.62 %. While revenue at the Labcorp Holdings Inc 's corporate clients recorded rose by 5.99 % year on year, sequentially revenue fell by -4.9 %.
Labcorp Holdings Inc's Customers have recorded an advance in their cost of revenue by 8.59 % in the 1 quarter 2026 year on year, sequentially costs of revenue were trimmed by -6.12 %, for the same period Labcorp Holdings Inc recorded revenue increase by 5.75 % year on year, sequentially revenue grew by 0.62 %.
Labcorp Holdings Inc's Comment on Sales, Marketing and Customers
The Company provides services to hospitals, health systems, local and regional laboratories, and biopharma customers. It offers comprehensive testing capabilities, including specialty testing in oncology, women’s health, autoimmune disease, and neurology. Through its Central Laboratory business, the Company supports clinical trials and has expanded specialty testing in Alzheimer’s disease diagnosis, molecular residual disease indication, and oncology. Additionally, it supports biopharma research and development in cell and gene therapy, with expanded laboratory capacity in Madison, Wisconsin.
Labcorp Holdings Inc’s Comment on Sales, Marketing and Customers
The Company provides services to hospitals, health systems, local and regional laboratories, and biopharma customers. It offers comprehensive testing capabilities, including specialty testing in oncology, women’s health, autoimmune disease, and neurology. Through its Central Laboratory business, the Company supports clinical trials and has expanded specialty testing in Alzheimer’s disease diagnosis, molecular residual disease indication, and oncology. Additionally, it supports biopharma research and development in cell and gene therapy, with expanded laboratory capacity in Madison, Wisconsin.
Sources:
Labcorp Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Labcorp Holdings Inc’s corporate clients.
For your research, we’ve provided 9 tables on Labcorp Holdings Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
0 %
3.99 %